ClinicalTrialsFinder
RecruitingNCT05482906

Common and Specific Information From Neuroimaging and Smartphone

Individual Gait Pattern and MRI Lesion Load to Quantify Gait Impairment in MS: A Cross Sectional Study.

Sponsor

Nantes University Hospital

Enrollment

100 participants

Start Date

Apr 3, 2023

Study Type

OBSERVATIONAL

Conditions

Multiple Sclerosis

Summary

Gait alteration is frequent in MS and limitation in walking ability is a major concern in MS patients. Umanit and LMJL (Nantes university) has developed a device call egait to assess walking ability in individuals (eg MS patients).

Eligibility

Min Age: 18 Years

Inclusion Criteria8

  • Diagnosis of MS based on McDonald criteria (including Relapsing-remitting and progressive MS)
  • Over 18 years old /age greater than 18 years
  • Patients followed at Nantes university hospital or Rennes university hospital
  • Last known EDSS before inclusion ranging from 0 to 6 inclusive/EDSS of 0 to 6 inclusive, prior inclusion
  • No relapse within 3 months
  • With a Medullar MRI planed as part as usual care
  • MRI scan can be performed within a maximum of 4 months after or before the walking test.
  • Affiliated person or beneficiary of a social security scheme

Exclusion Criteria4

  • Bilateral aid needed to walk
  • Women who are pregnant
  • Patient having expressed their opposition
  • Patient under guardianship or security measure

Interventions

OTHEReGait

IMU sensor (as part of eGait device) worn at the hip during T25FW

Locations(1)

Nantes University Hospital

Nantes, Loire-Atlantique, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05482906

Related Trials

From Genetics to Transcriptomics to Unravel the Mechanisms Behind a Poor Outcome in Multiple Sclerosis

NCT048734921 location

Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer

NCT0381634552 locations

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

NCT074776392 locations

Upper Limb Nerve Cryoneurolysis is Non Inferior to the Usual Care and Has Therapeutic Add Value in Dealing With Shoulder Pain and Functional Problems Caused by Spasticity and Motor Impairment

NCT067824641 location

Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

NCT072253611 location